100.931 makale bulundu

NAD+ signaling in Parkinson's disease: molecular mechanisms and therapeutic perspectives

Wang T, Zhou X, Chen X.

Frontiers in neurology · 2026-10-16

Acupuncture is associated with lower accidental injury risk among patients with Parkinson’s disease: a nationwide retrospective cohort study

Chou H, Wang M, Lin S.

Frontiers in neurology · 2026-10-16

Prediction of cognitive impairment in Parkinson’s disease using TabPFN: an integrative analysis of clinical data, longitudinal trajectories, and lipidomics

Zhou Z, Liu J, Wang L, Lv H, Jiang W, Huang L, Zhang G, Ma R.

Frontiers in aging neuroscience · 2026-10-16

The gut-brain axis in Alzheimer’s and Parkinson’s diseases: a comparative perspective

Upadhyay R, C. C, Kar S, Sathyamoorthy S, Pitchaimuthu X, Sevanan M.

Frontiers in microbiomes · 2026-10-16

Carotid atherosclerosis progression in patients with Parkinson’s disease: a prospective cohort study

Wang S, Yang N, Cheng H, Zhou Q.

Frontiers in aging neuroscience · 2026-10-16

ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson's disease.

Shu Z, Lam HA, Videlock EJ, Lindberg I, Maidment NT.

Transl Neurodegener · 2026-10-16

DOI: 10.1186/s40035-026-00593-xPMID: 42888454

Distinct handwriting kinematic profiles across Parkinson's disease subtypes.

Onder H, Dinc S, Yavuz Z, Comoglu S.

Parkinsonism Relat Disord · 2026-10-16

DOI: 10.1016/j.parkreldis.2026.109004PMID: 42906203

Omega-3 Status and Mental Health Symptoms in Parkinson’s Disease: Associations with Depression, Anxiety, and Apathy

Roberts EC, Murawska M, Mischley LK.

· 2026-10-15

DOI: 10.20944/preprints202610.1439.v1

Cross-Study Regulator-Activity Analysis Reveals Convergent Programs in alpha-Synuclein PFF Models of Parkinson’s Disease

Tang Y, Xiao A, Xiao Y, Li R, Huang Z, Wang A, Li L, Khan MM.

· 2026-10-15

DOI: 10.64898/2026.10.08.757683

Levodopa Preferentially Reorganizes Dorsal Subthalamic Activity in Parkinson’s Disease

Nair SS, Joshi P, Filyushkina V, Sayfulina K, Guha A, Sedov A, Shaikh AG.

· 2026-10-15

DOI: 10.64898/2026.10.13.26365259

Parkinson hastalığı gözetimi için biyoakışkan proteomlarda nörodejeneratif ve terapötik çaprazlamanın çözülmesi

Resolving neurodegenerative and therapeutic crosstalk in biofluid proteomes for Parkinson’s disease surveillance

Boyle EA, Paumier KL, Ruiz L, Voloboueva LA, Zaplatnikov Y, Hari A, Tiwari S, Hu W, Burrill M, Sheng E, Kirsch LC, Hiraga K, Tamakoshi D, Katsuno M, Hutten SJ, Frasier M, Galasko D, Chahine LM, Foroud T, Qureshi F, Merchant KM, Simuni T, Brazel DM, Mollenhauer B.

· 2026-10-15

DOI: 10.64898/2026.10.14.26364535

Parkinson hastalığının belirlenmesinde ticari atalet ölçüm birimi tabanlı yürüyüş sisteminin yeteneği: Kesitsel çalışmaların meta-analizi ile sistematik bir inceleme.

The ability of the commercial inertial measurement unit-based gait system in determining Parkinson's disease: A systematic review with meta-analysis of cross-sectional studies.

Pan J, Tang H.

PLoS One · 2026-10-15

DOI: 10.1371/journal.pone.0360793PMID: 42879463